NCT07270393Not yet recruiting
Study of the Influence of the Mediterranean Diet on the Quality of Life of Patients With Endometriosis.
Estudio de la Influencia de la Dieta mediterránea en la Calidad de Vida de Las Pacientes Con Endometriosis.
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The severities of chronic disease symptoms correlate with the levels of analytical parameters of inflammation. Studies have been published in which the Mediterranean diet has an anti-inflammatory phenomenon, decreasing inflammation parameters. This decrease correlates with an improvement in symptoms. Endometriosis is a chronic inflammatory disease and the influence of the Mediterranean diet on the decrease of inflammation parameters in women with endometriosis has been studied. The studies carried out to assess whether this decrease in inflammatory parameters correlates with clinical improvement and quality of life in these patients have low/very low scientific evidence (small sample size, no control group) and with different interventions (diets, restrictions and/or supplements), which prevent their analysis as a whole. Therefore, our hypothesis is that the Mediterranean diet, due to its anti-inflammatory effect, can improve the symptomatology and quality of life of patients with endometriosis.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- First submitted
- 26 Nov 2025
- Start date
- 1 Dec 2025
- Primary completion date
- 1 Dec 2026
- Lead sponsor
- Biogipuzkoa Health Research Institute
- Diseases
- Endometriosis
- NCT number
- NCT07270393
What you commit to
- Study type: Interventional
- Planned participants: 104
- From 1 Dec 2025 to the primary completion date, 1 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Other concomitant diseases that produce CPD.
- Change of treatment or surgery during follow-up.
- Surgery related to endometriosis or change of treatment in the 6 weeks prior to enrollment in the study.
- Drug abuse. Opioid analgesia \< 3 months.
Other illness
- Diagnosis of Eating Disorder.
- Diagnosis of malabsorptive syndromes: Chron's disease, Ulcerative colitis, short bowel syndrome, gastric by-pass, irritable bowel.
- Autoimmune diseases.-
- Metabolic diseases requiring follow-up of specific diets.
- Diagnosis of severe mental illness requiring treatment.
- Active cancer process.
- Personal history of gynecologic or digestive oncologic process.
Other
- Diagnosed gluten intolerance.
- Vegan diet.
- Follow-up by a nutritionist.
- Pregnancy or current breastfeeding.
Who the study is looking for
- Female.
- Age 18-45.
- Premenopausal status.
- Radiological diagnosis (by transvaginal ultrasound and/or MRI) and/or surgical diagnosis of endometriosis.
- Follow-up in the Gynecology Department of OSI Donostia (at least 1 visit in the last year).
- Clinical score of at least 3/10 on the Numerical Scale in at least one symptom related to endometriosis).
- Possibility of understanding Spanish.
- Possibility of understanding the indicated dietary recommendations.
- Acceptance of inclusion in clinical study, by signing informed consent.
Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitario Donostia (HUD) Coordinator of this site? Confirm its status | Donostia / San Sebastian | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.